BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1309294)

  • 1. Polycyclic aromatic hydrocarbon quinones may be either substrates for or irreversible inhibitors of the human placental NAD-linked 15-hydroxyprostaglandin dehydrogenase.
    Jarabak J
    Arch Biochem Biophys; 1992 Jan; 292(1):239-43. PubMed ID: 1309294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycyclic aromatic hydrocarbon quinone-mediated oxidation reduction cycling catalyzed by a human placental NADPH-linked carbonyl reductase.
    Jarabak J
    Arch Biochem Biophys; 1991 Dec; 291(2):334-8. PubMed ID: 1659323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycyclic aromatic hydrocarbon quinone-mediated oxidation reduction cycling catalysed by a human placental 17beta-hydroxysteroid dehydrogenase.
    Jarabak R; Harvey RG; Jarabak J
    Arch Biochem Biophys; 1996 Mar; 327(1):174-80. PubMed ID: 8615688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox cycling of polycyclic aromatic hydrocarbon o-quinones: metal ion-catalyzed oxidation of catechols bypasses inhibition by superoxide dismutase.
    Jarabak R; Harvey RG; Jarabak J
    Chem Biol Interact; 1998 Oct; 115(3):201-13. PubMed ID: 9851290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycyclic aromatic hydrocarbon quinones and glutathione thioethers as substrates and inhibitors of the human placental NADP-linked 15-hydroxyprostaglandin dehydrogenase.
    Chung HS; Harvey RG; Armstrong RN; Jarabak J
    J Biol Chem; 1987 Sep; 262(26):12448-51. PubMed ID: 3624267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on three reductases which have polycyclic aromatic hydrocarbon quinones as substrates.
    Jarabak J; Harvey RG
    Arch Biochem Biophys; 1993 Jun; 303(2):394-401. PubMed ID: 7685581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redox cycling of polycyclic aromatic hydrocarbon o-quinones: reversal of superoxide dismutase inhibition by ascorbate.
    Jarabak R; Harvey RG; Jarabak J
    Arch Biochem Biophys; 1997 Mar; 339(1):92-8. PubMed ID: 9056238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irreversible inhibition of the human placental NADP-linked 15-hydroxyprostaglandin dehydrogenase/9-ketoprostaglandin reductase by glutathione thiosulfonate.
    Chung H; Fried J; Jarabak J
    Prostaglandins; 1987 Mar; 33(3):391-402. PubMed ID: 3575754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substrate specificity of three prostaglandin dehydrogenases.
    Jarabak J; Luncsford A; Berkowitz D
    Prostaglandins; 1983 Dec; 26(6):849-68. PubMed ID: 6396732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of substrate specificities of the human placental NAD- and NADP-linked 15-hydroxyprostaglandin dehydrogenases.
    Jarabak J; Fried J
    Prostaglandins; 1979 Aug; 18(2):241-6. PubMed ID: 42948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity of polycyclic aromatic hydrocarbon o-quinones in rat and human hepatoma cells.
    Flowers-Geary L; Harvey RG; Penning TM
    Chem Res Toxicol; 1993; 6(3):252-60. PubMed ID: 7686407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutathione mixed disulfide inhibitors of the human placental NADP-linked 15-hydroxyprostaglandin dehydrogenase.
    Chung H; Fried J; Williams-Ashman E; Jarabak J
    Prostaglandins; 1987 Mar; 33(3):383-90. PubMed ID: 3575753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aromatic hydrocarbon quinone-mediated reactive oxygen species production on hepatic microsomes of the flounder (Platichthys flesus L.).
    Lemaire P; Livingstone DR
    Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1997 Jun; 117(2):131-9. PubMed ID: 9214713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic studies on 15-hydroxyprostaglandin dehydrogenase from human placenta.
    Schlegel W; Greep RO
    Adv Prostaglandin Thromboxane Res; 1976; 1():159-62. PubMed ID: 187034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of pulmonary NAD+-dependent 15-hydroxyprostaglandin dehydrogenase by acrolein.
    Liu Y; Tai HH
    Biochem Pharmacol; 1985 Dec; 34(24):4275-8. PubMed ID: 4074386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the human placental NAD- and NADP-linked 15-hydroxyprostaglandin dehydrogenases by nonsteroidal anti-inflammatory drugs.
    Jarabak J
    Prostaglandins; 1988 Mar; 35(3):403-11. PubMed ID: 3375453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NADP-linked 15-hydroxyprostaglandin dehydrogenase from human placenta: partial purification and characterization of the enzyme and identification of an inhibitor in placental tissue.
    Westbrook C; Lin YM; Jarabak J
    Biochem Biophys Res Commun; 1977 Jun; 76(3):943-9. PubMed ID: 20082
    [No Abstract]   [Full Text] [Related]  

  • 18. Endogenous inhibitor of 15-hydroxyprostaglandin dehydrogenase in human placenta.
    Nagai K; Mibe M; Mori N
    Prostaglandins Leukot Essent Fatty Acids; 1989 Dec; 38(3):157-61. PubMed ID: 2622970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early steps in prostaglandin metabolism in the human placenta.
    Jarabak J
    Am J Obstet Gynecol; 1980 Nov; 138(5):534-40. PubMed ID: 6252782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA strand scission by polycyclic aromatic hydrocarbon o-quinones: role of reactive oxygen species, Cu(II)/Cu(I) redox cycling, and o-semiquinone anion radicals,
    Flowers L; Ohnishi ST; Penning TM
    Biochemistry; 1997 Jul; 36(28):8640-8. PubMed ID: 9214311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.